Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: Relevance to neuropsychiatric disorders

Psychiatry Research

Volumn 219, Issue 3, 2014, Pages 674-679

  Santoro, Marcos Leite ^a,b   Santos, Camila Maurício ^a,b   Ota, Vanessa Kiyomi ^a,b   Gadelha, Ary ^a,b   Stilhano, Roberta Sessa ^a   Diana, Mariana Cepollaro ^a,b   Silva, Patrícia Natália ^a   Spíndola, Letícia Maria Nery ^a   Melaragno, Maria Isabel ^a   Bressan, Rodrigo Affonseca ^a,b   Han, Sang Won ^a   Abílio, Vanessa Costhek ^a,b   Belangero, Sintia Iole ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Interdisciplinary Laboratory of Clinical Neurosciences   (Brazil)

Author keywords

Chrnb4; DNA methylation; Gad2; Gene expression; Qrfpr; Slc5a7; Spontaneously hypertensive rats

Indexed keywords

NEUROTRANSMITTER RECEPTOR; CHRNB4 PROTEIN, MOUSE; COTRANSPORTER; G PROTEIN COUPLED RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; NERVE PROTEIN; NICOTINIC RECEPTOR; QRFPR PROTEIN, RAT; SLC5A7 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRNB4 GENE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GAD2 GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENETIC PROCEDURES; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSYCHOPATHY; QRFPR GENE; RAT; REGULATOR GENE; SLC5A7 GENE; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; WISTAR RAT; ANIMAL; ATTENTION DEFICIT DISORDER; DISEASE MODEL; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PSYCHOLOGY; SYNAPTIC TRANSMISSION; WISTAR KYOTO RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CPG ISLANDS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; MALE; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, NICOTINIC; SYMPORTERS; SYNAPTIC TRANSMISSION;

EID: 84907597287     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.05.034     Document Type: Article

References (43)

1. Ando R.D., Benko A., Ferrington L., Kirilly E., Kelly P.A., Bagdy G. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 2006, 50(7):884-896.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of Royal Statistical Society B: Methodology 1995, 57:289-300.
3. Bird A. DNA methylation patterns and epigenetic memory. Genes & development 2002, 16:6-21.
4. Bock C., Reither S., Mikeska T., Paulsen M., Walter J., Lengauer T. BiQ analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005, 21:4067-4068.
5. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., Swerdlow N.R. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research 2001, 49:171-178.
6. Cacabelos R., Martinez-Bouza R. Genomics and pharmacogenomics of schizophrenia. CNS Neuroscience & Therapeutics 2011, 17:541-565.
7. Calzavara M.B., Levin R., Medrano W.A., Almeida V., Sampaio A.P., Barone L.C., Frussa-Filho R., Abilio V.C. Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats. Behavioural Brain Research 2011, 225:15-22.
8. Calzavara M.B., Medrano W.A., Levin R., Kameda S.R., Andersen M.L., Tufik S., Silva R.H., Frussa-Filho R., Abilio V.C. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?. Schizophrenia Bulletin 2009, 35:748-759.
9. Calzavara M.B., Medrano W.A., Levin R., Libanio T.C., de Alencar Ribeiro, Abilio V.C. The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers. Progress in Neuropsychopharmacology & Biological Psychiatry 2011, 35:1607-1611.
10. Drexel M., Kirchmair E., Sperk G. Changes in the expression of GABAA receptor subunit mRNAs in parahippocampal areas after kainic acid induced seizures. Front Neural Circuits 2013, 7:142.
11. English B.A., Hahn M.K., Gizer I.R., Mazei-Robison M., Steele A., Kurnik D.M., Stein M.A., Waldman I.D., Blakely R.D. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. Journal of Neurodevelopmental Disorders 2009, 1:252-263.
12. Freese L., Muller E.J., Souza M.F., Couto-Pereira N.S., Tosca C.F., Ferigolo M., Barros H.M. GABA system changes in methylphenidate sensitized female rats. Behavioural Brain Research 2012, 231:181-186.
13. Fukusumi S., Fujii R., Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 2006, 27:1073-1086.
14. Grottick A.J., Bagnol D., Phillips S., McDonald J., Behan D.P., Chalmers D.T., Hakak Y. Neurotransmission- and cellular stress-related gene expression associated with prepulse inhibition in mice. Brain Research 2005, 139:153-162.
15. Heldt S.A., Green A., Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 2004, 29:1610-1619.
16. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophrenia Bulletin 2009, 35:549-562.
17. Igaz L.M., Bekinschtein P., Izquierdo I., Medina J.H. One-trial aversive learning induces late changes in hippocampal CaMKIIalpha, Homer 1a, Syntaxin 1a and ERK2 protein levels. Brain Research 2004, 132:1-12.
18. Laruelle M., Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology (Oxford, England) 1999, 13:358-371.
19. Levin R., Almeida V., Peres F.F., Calzavara M.B., da Silva N.D., Suiama M.A., Niigaki S.T., Zuardi A.W., Hallak J.E., Crippa J.A., Abilio V.C. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current Pharmaceutical Design 2012, 18:4960-4965.
20. Levin R., Calzavara M.B., Santos C.M., Medrano W.A., Niigaki S.T., Abilio V.C. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:1748-1752.
21. Matsuo A., Bellier J.P., Nishimura M., Yasuhara O., Saito N., Kimura H. Nuclear choline acetyltransferase activates transcription of a high-affinity choline transporter. Journal of Biological Chemistry 2011, 286:5836-5845.
22. Okuda T., Haga T., Kanai Y., Endou H., Ishihara T., Katsura I. Identification and characterization of the high-affinity choline transporter. Nature Neuroscience 2000, 3:120-125.
23. Okuda T., Konishi A., Misawa H., Haga T. Substrate-induced internalization of the high-affinity choline transporter. Journal of Neuroscience 2011, 31:14989-14997.
24. Papa M., Berger D.F., Sagvolden T., Sergeant J.A., Sadile A.G. A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of Attention Deficit Hyperactivity Disorder. Behavioural Brain Research 1998, 94:197-211.
25. Paxinos G., Watson C. The Rat Brain Stereotaxic Coordinates 1998, Academic Press, Sydney. (4th edition).
26. Russell V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behavioural Brain Research 2002, 130:191-196.
27. Sams-Dodd F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berlin) 1997, 132(3):303-310.
28. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neuroscience and Biobehavioral Reviews 2000, 24:31-39.
29. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse (New York, N.Y.) 1987, 1:133-152.
30. Sequeira P.A., Martin M.V., Vawter M.P. The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiology of Disease 2012, 45:23-36.
31. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PloS One 2007, 2:e895.
32. Skak K., Michelsen B.K. The TATA-less rat GAD65 promoter can be activated by Sp1 through non-consensus elements. Gene 1999, 236:231-241.
33. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends in Pharmacological Sciences 1998, 19:500-505.
34. Stephens S.H., Logel J., Barton A., Franks A., Schultz J., Short M., Dickenson J., James B., Fingerlin T.E., Wagner B., Hodgkinson C., Graw S., Ross R.G., Freedman R., Leonard S. Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophrenia Research 2009, 109:102-112.
35. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Molecular Psychiatry 2002, 7:542-559.
36. Tong L., Shen H., Perreau V.M., Balazs R., Cotman C.W. Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiology of Disease 2001, 8:1046-1056.
37. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nature Reviews Genetics 2012, 13:227-232.
38. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry 2000, 57:237-245.
39. Wang B., Yang L., Wang Z., Zheng H. Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14140-14145.
40. Weinberger D.R. From neuropathology to neurodevelopment. Lancet 1995, 346:552-557.
41. Winterer G., Mittelstrass K., Giegling I., Lamina C., Fehr C., Brenner H., Breitling L.P., Nitz B., Raum E., Muller H., Gallinat J., Gal A., Heim K., Prokisch H., Meitinger T., Hartmann A.M., Moller H.J., Gieger C., Wichmann H.E., Illig T., Dahmen N., Rujescu D. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:1448-1458.
42. Wultz B., Sagvolden T., Moser E.I., Moser M.B. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behavioral and Neural Biology 1990, 53:88-102.
43. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D.L. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. The Journal of Biological Chemistry 1999, 274:34893-34902.